Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial

Author(s):: Broekhuijsen, K.; Baaren, G.J. van; Pampus, M.G. van; Ganzevoort, W.; Sikkema, J.M.; Woiski, M.D.; Oudijk, M.A.; Bloemenkamp, K.W.M.; Scheepers, H.C.J.; Bremer, H.A.; Rijnders, R.J.P.; Loon, A.J. van; Perquin, D.A.M.; Sporken, J.M.J.; Papatsonis, D.N.M.; Huizen, M.E. van; Vredevoogd, C.B.; Brons, J.T.J.; Kaplan, M.; Kaam, A.H. van; Groen, H.; Porath, M.M.; Berg, P.P. van den; Mol, B.J.; Franssen, M.T.M.; Langenveld, J.; HYPITAT-II Study Grp